Clinical Trial Update: CARDIO-TTRansform Magnetic Resonance Imaging (MRI) Sub-study

View source ↗

Summary

This update describes the CARDIO-TTRansform MRI sub-study for transthyretin-mediated amyloid cardiomyopathy sponsored by Ionis Pharmaceuticals; the trial is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin-mediated Amyloid Cardiomyopathy

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) | Status: ACTIVE_NOT_RECRUITING